ROBERT CHRISTENSEN: Open Payments
NPI 1417993726 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 49 payments from 20 companies in 2025. Trend: 2023 $972 · 2024 $969 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $170 |
| Dexcom, Inc. | 3 | $106 |
| Amgen Inc. | 5 | $89 |
| Novo Nordisk Inc | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Xeris Pharmaceuticals, Inc. | 1 | $71 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Exact Sciences Corporation | 2 | $36 |
Products named: NURTEC ODT, Dexcom G6 Transmitter, KEVEYIS, OTEZLA, SHINGRIX, AIRSUPRA, Rybelsus, CAPLYTA.
Industry payments across SC — which companies pay providers there.
